» Articles » PMID: 32504360

SARS-CoV-2 Infection in Infants Under 1 year of Age in Wuhan City, China

Overview
Journal World J Pediatr
Specialty Pediatrics
Date 2020 Jun 7
PMID 32504360
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The clinical characteristics and outcome of COVID-19 in children are different from those in adults. We aimed to describe the characteristics of infants under 1 year of age (excluding newborns) with COVID-19.

Methods: We retrospectively retrieved data of 36 infants with SARS-CoV-2 infection in Wuhan Children's Hospital from January 26 to March 22, 2020. Clinical features, chest imaging findings, laboratory tests results, treatments and clinical outcomes were analyzed.

Results: The mean age of the infected infants was 6.43 months, with a range of 2-12 months. 61.11% of the patients were males and 38.89% females. 86.11% of the infants were infected due to family clustering. Cough (77.78%) and fever (47.22%) were the most common clinical manifestations. Chest CT scan revealed 61.11% bilateral pneumonia and 36.11% unilateral pneumonia. 47.22% of the infants developed complications. Increased leucocytes, neutrophils, lymphocytes, and thrombocytes were observed in 11.11, 8.33, 36.11 and 44.44% of infants, respectively. Decreased leucocytes, neutrophils, thrombocyte and hemoglobin were observed in 8.33, 19.44, 2.78 and 36.11% of infants, respectively. Increased C-reactive protein, procalcitonin, lactate dehydrogenase, alanine aminotransferase, creatine kinase and D-dimer were observed in 19.44, 67.74, 47.22, 19.44, 22.22 and 20.69% of infants, respectively. Only one infant had a high level of creatinine. Co-infections with other respiratory pathogens were observed in 62.86% of infants. CD3 (20.69%), CD4 (68.97%), CD19 (31.03%) and Th/Ts (44.83%) were elevated; CD8 (6.9%) and CD16+CD56 (48.28%) was reduced. IL-4 (7.69%), IL-6 (19.23%), IL-10 (50%), TNF-α (11.54%) and IFN-γ (19.23%) were elevated. Up to March 22, 97.22% of infants recovered, while a critical ill infant died. When the infant's condition deteriorates rapidly, lymphocytopenia was discovered. Meanwhile, C-reactive protein, D-dimer, alanine aminotransferase, creatine kinase, creatinine, IL-6 and IL-10 increased significantly.

Conclusions: In the cohort, we discovered that lymphocytosis, elevated CD4 and IL-10, and co-infections were common in infants with COVID-19, which were different from adults with COVID-19. Most infants with COVID-19 have mild clinical symptoms and good prognosis.

Citing Articles

Chest CT Scan Findings in Children with COVID-19: A Systematic Review.

Oraya D, Militante S, Dans L, Lozada M, Valle A, Cabaluna I Acta Med Philipp. 2024; 58(7):110-128.

PMID: 38882921 PMC: 11168958. DOI: 10.47895/amp.v58i7.6385.


Global Coinfections with Bacteria, Fungi, and Respiratory Viruses in Children with SARS-CoV-2: A Systematic Review and Meta-Analysis.

Alhumaid S, Alabdulqader M, Al Dossary N, Al Alawi Z, Alnaim A, Al Mutared K Trop Med Infect Dis. 2022; 7(11).

PMID: 36422931 PMC: 9698370. DOI: 10.3390/tropicalmed7110380.


Clinical and Laboratory Characteristics of Pediatric COVID-19 Population-A Bibliometric Analysis.

Maniu I, Maniu G, Totan M J Clin Med. 2022; 11(20).

PMID: 36294306 PMC: 9605229. DOI: 10.3390/jcm11205987.


Thyroid diseases are associated with coronavirus disease 2019 infection.

Tian Y, Zhao J, Wang T, Wang H, Yao J, Wang S Front Endocrinol (Lausanne). 2022; 13:952049.

PMID: 36120425 PMC: 9478801. DOI: 10.3389/fendo.2022.952049.


A Clinical Profile of Pediatric COVID-19 Testing in the Emergency Department, Dubai, United Arab Emirates.

Farid Mir F, Saleh M Int J Pediatr. 2022; 2022:5092259.

PMID: 35992890 PMC: 9391184. DOI: 10.1155/2022/5092259.


References
1.
Zheng F, Liao C, Fan Q, Chen H, Zhao X, Xie Z . Clinical Characteristics of Children with Coronavirus Disease 2019 in Hubei, China. Curr Med Sci. 2020; 40(2):275-280. PMC: 7095065. DOI: 10.1007/s11596-020-2172-6. View

2.
Fu Y, Cheng Y, Wu Y . Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools. Virol Sin. 2020; 35(3):266-271. PMC: 7090474. DOI: 10.1007/s12250-020-00207-4. View

3.
Guan W, Ni Z, Hu Y, Liang W, Ou C, He J . Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020; 382(18):1708-1720. PMC: 7092819. DOI: 10.1056/NEJMoa2002032. View

4.
Xu X, Wu X, Jiang X, Xu K, Ying L, Ma C . Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2020; 368:m606. PMC: 7224340. DOI: 10.1136/bmj.m606. View

5.
Zhang Y, Li J, Zhan Y, Wu L, Yu X, Zhang W . Analysis of serum cytokines in patients with severe acute respiratory syndrome. Infect Immun. 2004; 72(8):4410-5. PMC: 470699. DOI: 10.1128/IAI.72.8.4410-4415.2004. View